{"id":9380,"date":"2026-06-08T06:35:02","date_gmt":"2026-06-08T04:35:02","guid":{"rendered":"https:\/\/eurotext.de\/en\/?p=9380"},"modified":"2026-06-10T07:28:29","modified_gmt":"2026-06-10T05:28:29","slug":"the-healthcare-market-in-poland","status":"publish","type":"post","link":"https:\/\/eurotext.de\/en\/blog\/the-healthcare-market-in-poland\/","title":{"rendered":"The healthcare market in Poland"},"content":{"rendered":"

The Polish healthcare system has been chronically underfunded for many years, which is reflected in staff shortages and access issues like long waiting times and high co-payments. But a transformation is underway: national initiatives and EU-level funding programs are aimed at changing things for the better \u2013 for patients and also for manufacturers of medical technology and pharmaceutical products, who can look forward to exciting new sales opportunities. <\/p>\n

Population<\/h2>\n

With around 38 million inhabitants, Poland ranks among the most populous countries in the\u00a0 EU after Germany<\/a>, UK, France<\/a>, Italy<\/a>, and Spain<\/a>. The nation\u2019s population is also relatively young: in 2022, only 18.6% were over 65 years old. Life expectancy, however, is a little lower compared to the United Kingdom<\/a>, with 79.3 years vs. 81.77 years. Nearly half of all deaths in Poland can be attributed to behavioral factors like smoking, excessive alcohol consumption, or a sedentary lifestyle. In addition, almost one in five Polish adults is obese.<\/p>\n

The main causes of death (pre-Covid) included ischemic heart disease, stroke, and lung cancer. Despite overall lower cancer incidence rates compared to the UK, mortality rates are higher, indicating issues with timely diagnosis and treatment. In 2021, the most common types of cancer<\/a> in men were lung cancer, prostate cancer, and colorectal cancer. In women, breast cancer was most common, followed by lung cancer, colorectal cancer, and cervical cancer. To address these developments, Poland has recently launched several initiatives geared toward strengthening cancer prevention and treatment.<\/p>\n

Structure, Pressures, and Opportunities for Global MedTech Stakeholders<\/h2>\n

A Changing Healthcare Landscape in the Heart of the European Union<\/h4>\n

Poland\u2019s healthcare market has entered a decisive period of transformation. As one of the EU\u2019s largest member states by population, the country is reshaping its health system to address demographic pressures, workforce shortages, and rising demand for digital and pharmaceutical innovation. The Poland Country Health Profile 2025<\/em> highlights a system under strain but also one that is investing heavily in resilience, infrastructure, and modernization. For international MedTech manufacturers and regulatory teams, these shifts create a landscape in which demand for advanced technologies, diagnostics, and digital solutions grows faster than the system\u2019s ability to supply them.<\/p>\n

Population Dynamics and the Drivers of Healthcare Demand<\/h2>\n

Poland\u2019s demographic profile continues to evolve. Chronic diseases are rising, and regional disparities in access to care remain significant. The 2025 EU health profile notes that pressures on service delivery are increasing, especially in primary care and specialist services. These demographic trends are reshaping national priorities. The government is focusing on strengthening preventive care, improving early diagnosis, and expanding digital health tools that can compensate for workforce shortages. For MedTech companies, this creates a clear demand for remote monitoring devices, AI\u2011supported diagnostics, and interoperable digital platforms<\/a> that can integrate with national health data systems.<\/p>\n

How the Polish Healthcare System Is Structured<\/h2>\n

Poland operates a social health insurance model funded primarily through mandatory contributions. The National Health Fund (NFZ) remains the central payer, and the system is supported by a mix of public and private providers. According to the 2025 profile, the government is prioritizing stronger health infrastructure, improved crisis preparedness, and long\u2011term sustainability.
\nDespite these efforts, the system continues to face challenges. Workforce shortages, long waiting times, and uneven access to specialist care persist. These structural issues create opportunities for MedTech solutions that can streamline workflows, reduce administrative burdens, and support clinical decision\u2011making.<\/p>\n

Poland Within the EU: Alignment, Obligations, and Strategic Positioning<\/h2>\n

As an EU member state, Poland participates fully in the European Health Union framework. The 2025 Country Health Profiles emphasize the alignment of national reforms with major EU initiatives, including Europe\u2019s Beating Cancer Plan, the Pharmaceutical Strategy for Europe, and the European Health Data Space.
\nThis alignment matters for international manufacturers because it ensures regulatory harmonization, predictable market access pathways, and participation in cross\u2011border data and research networks. Poland\u2019s integration into EU\u2011wide health strategies also accelerates demand for advanced oncology technologies, digital therapeutics, and interoperable data systems.<\/p>\n

The Existing Healthcare Industry and Its Growth Trajectory<\/h2>\n

Poland\u2019s healthcare industry has expanded steadily over the past decade. The pharmaceutical sector receives special attention in the 2025 profile, which highlights ongoing reforms and investments aimed at improving access, strengthening supply chains, and supporting innovation.
\nMedical technology adoption is rising, driven by hospital modernization programs and the need to replace aging equipment. Digital health has become a national priority, with telemedicine, e\u2011prescriptions, and electronic patient records now embedded in routine care. These developments create a receptive environment for international MedTech companies offering scalable, compliant, and user\u2011friendly solutions.<\/p>\n

Trends Shaping the Market in 2026<\/h2>\n

Several trends define the Polish healthcare market in 2026. The first is the push for digital innovation, which the 2025 profile identifies as essential for long\u2011term sustainability.
\nThe second is the need to strengthen health infrastructure and workforce capacity. Hospitals are investing in automation, advanced imaging, and AI\u2011supported triage tools to manage rising demand. The third is the growing emphasis on crisis preparedness, shaped by lessons from recent global health emergencies. This has increased interest in remote diagnostics, mobile health units, and resilient supply chains. Finally, the pharmaceutical spotlight in the EU profiles underscores a broader shift toward integrated care pathways, precision medicine, and improved access to innovative therapies.<\/p>\n

Regulatory Requirements and Market Entry Considerations<\/h2>\n

Poland follows the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), ensuring alignment with European standards. For international manufacturers, this means that CE marking, clinical evaluation, and post\u2011market surveillance requirements mirror those across the EU. The 2025 EU health profiles also highlight ongoing reforms linked to the European Health Data Space, which will influence data governance, interoperability, and digital\u2011health compliance. Market entry typically involves cooperation with local distributors, registration with the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, and alignment with NFZ reimbursement pathways. For companies offering digital solutions, integration with national e\u2011health platforms is increasingly important.<\/p>\n

Opportunities for the Future: Where MedTech Can Make an Impact<\/h2>\n

Poland\u2019s healthcare system is under pressure, but it is also investing in modernization. The 2025 profile identifies digital innovation, infrastructure strengthening, and workforce support as national priorities. These priorities create opportunities in several areas. Advanced imaging and diagnostic technologies can help reduce waiting times. Remote monitoring tools can support chronic\u2011disease management in an aging population. AI\u2011driven triage and workflow automation can ease the burden on overstretched clinical teams.
\nPharmaceutical reforms and EU\u2011aligned strategies also open the door for precision\u2011medicine tools, companion diagnostics, and integrated oncology solutions. For translation and localization professionals, the rapid expansion of digital health and cross\u2011border data exchange increases demand for high\u2011quality multilingual documentation<\/a> and regulatory content.<\/p>\n

Bottom Line<\/h2>\n

Poland\u2019s healthcare market in 2026 is defined by demographic pressure, structural challenges, and a strong commitment to modernization. The latest EU health profiles show a system investing in resilience, digital transformation, and long\u2011term sustainability. For international MedTech manufacturers, regulatory affairs teams, and product and marketing leaders, Poland offers a growing market with clear needs: better diagnostics, stronger digital infrastructure, and technologies that support clinicians and patients. As part of the EU, Poland provides a predictable regulatory environment and access to a large, integrated health\u2011policy framework. The country\u2019s direction is clear. It is building a more resilient, digitally enabled healthcare system, and it is actively seeking solutions that can help it meet the challenges of the next decade. For global MedTech innovators, Poland not only a promising market but also a strategic gateway to Central and Eastern Europe.<\/p>\n
\r\n

\r\n
Would you like to get to know more about healthcare worldwide?<\/div>\r\n
Healthcare Markets<\/a><\/div>\r\n<\/div>\r\n
\n

Sources<\/h2>\n